- Global Pharma News & Resources

Increase in eye cancer cases will boost the uveal melanoma treatment market, forecast to grow at a CAGR of 13%

Noida, Uttar Pradesh, India, February 25 2021 (Wiredrelease) Report Ocean Pvt Ltd –:Global Uveal melanoma treatment Market is estimated to see healthy growth, pegged at a CAGR of ~13% during the forecast period 2020-2025. The global market for uveal melanoma treatment is mainly driven by an increase in eye cancer incidence cases. One of the significant factors for the surge is the rise in the use of electronic devices. This may be due to harmful UV radiation that directly affects users’ eyes, tablets, desktops, laptops, and other electronic devices. For instance, according to the American Cancer Society, adults aged 60 years and above spend five or more hours per day using digital devices and prefer laptops & desktops for internet browsing. Thus, this, in turn, is expected to increase the uveal melanoma treatment market’s growth.

Download Detailed COVID-19 Impact Sample Report at @

People with a weak immune system are vulnerable to the development of eye cancer. However, governments of various countries are taking significant initiatives to provide better treatment at a minimal cost. Thus, this is, in turn, is supporting the growth of the uveal melanoma treatment market.

How Discovery of Novel Biomarkers Fueling Demand for Uveal melanoma Treatment?

Increased awareness and growing use of unique biomarkers, including blood biomarkers in the diagnosis and treatment of uveal melanoma, improve the detection accuracy and time spent on the process, which fuels the uveal’s revenue opportunities melanoma market. Besides, technological developments in biotechnology have improved the identification of possible biomarkers of uveal melanoma.

Some of the new biomarkers adopted for the diagnosis and progression of uveal melanoma include genetic, histological, radiographic, and physiological diagnoses, which are expected to fuel the Uveal melanoma treatment market growth.

Opportunities and Challenges for Uveal melanoma Treatment

The development of an efficient screening tool for uveal melanoma will play a significant role in early detection and subsequent mortality reduction. Over the past few decades, recognition and screening for uveal melanoma have improved, leading to the early detection of uveal melanoma. The ultimate aim of reducing the rate of late-stage illness and mortality has not been achieved.

This is primarily due to inadequate screening techniques, which also yield false-positive and false-negative findings. To meet these criteria, groundbreaking companion diagnostic tests will lead to rapid acceptance among doctors and patient populations. Therefore, the growing demand for safe non-invasive screening methods is expected to fuel the uveal melanoma treatment market’s growth during the forecast period.

Different factors hinder the growth of uveal melanoma treatment markets, such as the need for adequate skills and experience from conducting uveal melanoma treatment surgeries to provide high-quality and effective treatment services for uveal melanoma. The demand for specialists and trained practitioners to perform these surgeries globally has risen in the number of uveal melanoma treatment surgeries. However, it is expected that a lack of awareness about early signs of eye cancer will deter the development of the global uveal melanoma market.

Segmentation Overview of the Global Uveal Melanoma Treatment Market

The uveal melanoma treatment market has been segmented into Location Type, Diagnostic Tests, Eye Exams, and End User. These major market segments are further categorized into various sub-segments to study the market in detail.

By Location Type (Iris Melanoma, Choroid Melanoma, Ciliary Melanoma)
By Diagnostic Tests (High Resolution Ultrasound Biomicroscopy, Fluorescein Angiography, Ultrasonography, Ocular Coherence Tomography, Indocyanine Green Angiography)
By Eye Exams (Gonioscopy, Ophthalmoscopy, Slit-Lamp Biomicrocopy)
By End User (Hospitals, Ambulatory Surgical Centers, Ophthalmology Clinics, Others)

Key Players Insights

Eli Lilly & Co., Spectrum Pharmaceuticals, Inc., Novartis AG, Bayer, Astra Zeneca plc, Merck, Amgen, Pfizer, Inc., and Roche., among others, are some significant players included in the research study of the global uveal melanoma treatment market.

To Get the Sample Copy of Report Visit @

This content has been published by Report Ocean Pvt Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 25-Feb-2021